These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24605351)

  • 1. Woronoff ring associated with adalimumab therapy for psoriasis.
    Park KK; Swan JW; Eilers D; Tung R; Koo J
    Cutis; 2014 Feb; 93(2):E1-2. PubMed ID: 24605351
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute pain management in an unusual case of psoriasis.
    Eipe N; Penning J
    Can J Anaesth; 2012 Oct; 59(10):999-1000. PubMed ID: 22826181
    [No Abstract]   [Full Text] [Related]  

  • 3. Refractory generalized pustular psoriasis responsive to a combination of adalimumab and acitretin.
    Gallo E; Llamas-Velasco M; Daudén E; García-Diez A
    Int J Dermatol; 2013 Dec; 52(12):1610-1. PubMed ID: 22834488
    [No Abstract]   [Full Text] [Related]  

  • 4. ["MGUS": a potentially under diagnosed event during anti-TNF-α treatment of psoriasis?].
    Schmutz JL; Trechot P
    Ann Dermatol Venereol; 2013 Feb; 140(2):157-8. PubMed ID: 23395504
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cutaneous pseudolymphoma with two types of anti-TNFα: a class effect?].
    Schmutz JL; Trechot P
    Ann Dermatol Venereol; 2012 Oct; 139(10):695-6. PubMed ID: 23122389
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study.
    Esposito M; Giunta A; Mazzotta A; Zangrilli A; Babino G; Bavetta M; Perricone R; Chimenti S; Chimenti MS
    Dermatology; 2012; 225(4):312-9. PubMed ID: 23295383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crohn's disease diagnosis during adalimumab treatment.
    Fernández Salazar L; Barrio Andrés J; González Hernández JM
    Scand J Gastroenterol; 2013 Feb; 48(2):254-5. PubMed ID: 23061423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis.
    Revicki D; Willian MK; Saurat JH; Papp KA; Ortonne JP; Sexton C; Camez A
    Br J Dermatol; 2008 Mar; 158(3):549-57. PubMed ID: 18047521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Woronoff Ring in Psoriasis and the Mechanisms of Postinflammatory Hypopigmentation.
    Prinz JC
    Acta Derm Venereol; 2020 Jan; 100(3):adv00031. PubMed ID: 31971604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alopecia areata universalis elicited during treatment with adalimumab.
    Pelivani N; Hassan AS; Braathen LR; Hunger RE; Yawalkar N
    Dermatology; 2008; 216(4):320-3. PubMed ID: 18230980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of sarcoidosis during adalimumab therapy for chronic plaque psoriasis.
    Marcella S; Welsh B; Foley P
    Australas J Dermatol; 2011 Aug; 52(3):e8-11. PubMed ID: 21834808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infective endocarditis complicating adalimumab therapy for psoriasis.
    Haque Hussain SS; Wallace M; Belham M; Rusk R; Carmichael AJ; Wells FC; Burrows NP
    Clin Exp Dermatol; 2014 Jun; 39(4):555-6. PubMed ID: 24708155
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of spondyloarthritides with anti-TNFalpha biologic agents.
    Braun J
    Reumatismo; 2006; 58 Spec No.1():71-2. PubMed ID: 23631067
    [No Abstract]   [Full Text] [Related]  

  • 14. Adalimumab desensitization protocol in a patient with a generalized urticarial reaction and angioedema following adalimumab administration.
    Gutiérrez Fernández D; Foncubierta Fernández A; Anguita Carazo JL; Fernández Meléndez S; Fernández Anguita MJ; Medina Varo F
    J Investig Allergol Clin Immunol; 2014; 24(4):273-5. PubMed ID: 25219112
    [No Abstract]   [Full Text] [Related]  

  • 15. Kaposi's sarcoma associated with treatment with adalimumab.
    Amadu V; Satta R; Montesu MA; Cottoni F
    Dermatol Ther; 2012; 25(6):619-20. PubMed ID: 23210762
    [No Abstract]   [Full Text] [Related]  

  • 16. Malignancies developing in obese patients with psoriasis while on antitumour necrosis factor-α therapies: a case series.
    Sadlier M; Lally A; Kirby B
    Br J Dermatol; 2012 Oct; 167(4):937-8. PubMed ID: 22428935
    [No Abstract]   [Full Text] [Related]  

  • 17. Central retinal vein occlusion and subsequent neovascular glaucoma after adalimumab treatment for psoriasis.
    Hsu CK; Cheng CY; Hung JH; Li ML; Huang FC; Yang WL; Lee JY
    Clin Exp Dermatol; 2014 Jan; 39(1):72-3. PubMed ID: 23692635
    [No Abstract]   [Full Text] [Related]  

  • 18. Palmoplantar subcorneal pustular dermatosis following adalimumab therapy for rheumatoid arthritis.
    Sauder MB; Glassman SJ
    Int J Dermatol; 2013 May; 52(5):624-8. PubMed ID: 23489057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flare and change of psoriasis morphology during the course of treatment with tumour necrosis factor blockers.
    Goiriz R; Daudén E; Pérez-Gala S; Guhl G; García-Díez A
    Clin Exp Dermatol; 2007 Mar; 32(2):176-9. PubMed ID: 17176269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palmoplantar and scalp psoriasis occurring during anti-tumour necrosis factor-alpha therapy: a case series of four patients and guidelines for management.
    Papadavid E; Gazi S; Dalamaga M; Stavrianeas N; Ntelis V
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):380-2. PubMed ID: 18269613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.